Author

Amy Taylor

University of California San DiegoPrimary ORCID profile (0000-0001-9811-330X · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Amy TayloriD2 papers · Community Health Center

Biology Disciplines

Click to filter author papers

Genomics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:long-read sequencing· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron Jacobs· 1 shared ALAN E. KIMURAiD· 1 shared Alex Lehmann· 1 shared Anasha Arryman· 1 shared Beatrice Xuan Ho· 1 shared Boon-Seng SohiD· 1 shared Brent Banasik· 1 shared Brittany N. KesiciD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aaron Jacobs

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sequencing by Expansion (SBX) -- a novel, high-throughput single-molecule sequencing technology

Mark S. Kokoris, Robert N. McRuer, Melud Nabavi, Aaron Jacobs, Marc J. Prindle, Cynthia Cech, Kendall Berg, Taylor Lehmann, Cara Machacek, John C. Tabone, Jagadeeswaran Chandrasekar, Lacey McGee, Matthew Lopez, Tommy Reid, Cara Williams, , Matthew Corning

This paper introduces SBX, a single-molecule sequencing technology that improves nanopore sequencing accuracy and scalability by encoding DNA into Xpandomers with high signal-to-noise reporter codes.

bioRxiv · Feb 19, 2025 · PreprintGenomics

ALS Motor Neurons Exhibit Hallmark Metabolic Defects That Are Rescued by Nicotinamide and SIRT3 Activation

Jin‐Hui Hor, Munirah Mohamad Santosa, Valerie Jing Wen Lim, Beatrice Xuan Ho, Amy Taylor, Zi Jian Khong, John Ravits, Yong Fan, Yih‐Cherng Liou, Boon-Seng Soh, Shi‐Yan Ng

This study identifies metabolic defects in ALS motor neurons and shows that nicotinamide and SIRT3 activation can rescue these defects.

Cell Death and Differentiation · Nov 12, 2020Peer-reviewedNeuroscience